IBA
IBA
1,47 %
15,90 EUR
0,23
Kurs
15,90
Hög
16,00
Förändring
1,47 %
Låg
15,69
Uppdaterad
2019-09-13
Öppen
16,00
Factsheet for IBA
Company Profile
Description
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and Rest of World, with REst-of-World sales generating the largest proportion of revenue.
Key Stats
Website: http://www.iba-worldwide.com
Headquarter country: Belgium
Employees: 1 000
Market Cap (at close 27-08-2019): EUR 505M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 41,40 61,30 22,10 31,40
Forward Price/Earnings 11,90 28,10 32,10 23,10
Price/Free Cash Flow 203,00 164,40 78,50 8,90
Return on Assets -1,20 -11,00 6,30 17,40 8,30
Return on Equity -4,20 -30,30 15,60 45,10 27,80
Return on Invested Capital -0,60 -22,50 13,50 37,30 20,90
Dividend


Dividend/Share:0,30
Ex. Dividend Date:2017-12-31
Trailing Dividend Yield:1,22
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 208,44 287,42 328,77 270,36 220,58
Gross Profit 0,07 0,09 0,14 0,11 0,10
Gross Margin % 33,15% 33,02% 42,14% 42,04% 43,57%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 4,00 -12,00 34,00 71,00 23,00
Net income -4,00 -39,00 24,00 61,00 24,00
Basic Earnings Per Share -0,15 -1,34 0,85 2,17 0,89
Operating Income 0,00 -0,01 0,03 0,03 0,02
Operating Margin % 0,12% -4,32% 9,59% 10,71% 10,15%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -19,00 -45,00 -17,00 45,00 15,00
Capital Expenditures -19,00 -15,00 -13,00 -4,00 -5,00
Free Cash Flow -37,00 -60,00 -30,00 41,00 10,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 312,97 257,83 296,76 323,88 204,36 188,45
Long Term Assets 79,16 74,69 83,86 71,47 102,70 93,31
Total Assets 392,13 332,52 380,62 395,35 307,06 281,75
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 227,31 188,93 186,44 205,87 158,44 161,48
Long Term Liabilities 43,78 25,85
Total Liabilities 230,23 231,72
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 15,08 20,94 68,37 84,26 26,79 2,79
Treasury Stock 8,50 8,50 8,50 8,50 8,61 8,61
Total Stockholder Equity 103,09 108,69 150,39 163,63 107,53 67,24
Net Tangible Assets 94,37 92,48 136,60 151,18 94,53 54,35